Copy to clipboard 
In the heart of Germany’s precision metalworking region, near Pforzheim, Mebus MIM-Technik GmbH has consistently built a reputation for doing what others can’t: transforming metal powders into miniature, complex, high-precision mass components used in the most demanding and regulated industries. Now celebrating its 20th anniversary, the company is entering a new era backed by the Acrotec Group, and poised to scale its impact across medtech.
Founded in 2005 in Neuhausen, Germany, Mebus is a specialist in metal injection molding (MIM), ceramic injection molding (CIM) and technical plastic molding, with deep expertise in metallurgy, sintering, and tool design. Over two decades, it has carved a niche as a reliable and trusted problem solver for customers requiring micro-components with ultra-fine tolerances, internal geometries, and tight deadlines.
Shaping Precision from Powder
Mebus’ core strength lies in engineering and serial production of components using powder metallurgy processes. Its in-house capabilities span feedstock development, tooling, injection molding, debinding, sintering, hardening, laser cutting, and surface finishing.
With several injection molding machines and more than 10 industrial sintering furnaces, the company manufactures millions of components annually, from surgical instruments and dental brackets to precision elements for optics and mechanical engineering. Recent investments include a new sinter furnace qualified in September 2025, increasing capacity and efficiency.
The advantages of MIM over CNC machining or additive manufacturing are clear when it comes to scaling up complex parts: extremely lower material waste, shorter production cycles, and highly consistent quality, especially for intricate geometries with internal channels of micrometer scale.
An Engineering Mindset That Makes the Impossible, Possible
“Many of our customers tell us that other injection molders have turned them down and are not able to meet their part requirements,” says Pouya Moghimian, Ph.D., CEO of Mebus. “Our team thrives on quality and complexity. Whether it’s the material selection and development, geometry, or tolerance, we aim to deliver what others consider unfeasible.”
That spirit has made Mebus a preferred partner for leading medical device manufacturers in Germany and across Europe. The company is ISO 9001 and ISO 13485 certified, ensuring full traceability, quality control and regulatory compliance.
What sets Mebus apart is its end-to-end control: the company designs its own molds, co-develops the feedstock with suppliers, and adapts its processes for each customer’s functional needs, whether using stainless steel, titanium, tungsten, ceramics or technical plastics.
Now Part of the Acrotec Medtech Division
Since November 2024, Mebus has been part of the Acrotec Group, a Swiss industrial group of 2,800-plus employees with strongholds in medtech, watchmaking, and high-tech precision manufacturing. Within this structure, Mebus serves as the Group’s exclusive center of excellence for MIM, CIM, and plastic injection molding.
Mebus not only contributes to Acrotec’s global projects but also gains access to shared expertise, market reach, and international clients, particularly in the U.S. and Ireland, two strategic expansion areas. Mebus also plays a vital role in helping Acrotec Medtech offer a “one-stop-shop” solution in contract manufacturing for the medical sector.
“We’re no longer just a niche MIM player. We’re a technology driver within a larger ecosystem,” Dr. Moghimian said. “That gives us the resources and partners to scale, invest, innovate, and grow sustainably.”
Expanding Horizons — From Medtech to Aerospace and Watchmaking
While medtech remains Mebus’ strategic core business, its roadmap includes expanding into watchmaking, where it’s developing reliable tungsten injection molding processes, as well as aerospace, where regulation, material properties and complex geometries present new challenges Mebus is ready to take on.
Robotic automation has already been added to boost manufacturing efficiency and repeatability, while R&D continues to focus on cost-efficient, high-performance solutions. The company’s Neuhausen facility offers physical room for expansion, with future plans tied to market demand.
Pouya Moghimian, Ph.D.
Sustainability, Innovation and Governance
Dr. Moghimian’s leadership brings together visionary commercial leadership and hands-on technical and scientific rigor. He has steered the company toward growth through targeted investments, customer-centric strategies, and scalable operations. Alongside his executive role, he is also a recognized author on metal industry challenges such as sustainable supply chain, qualification pathways, and recyclability.
“We’re investing not just in cutting-edge technologies, but also in our people and safety,” Dr. Moghimian said. “Sustainable manufacturing, customer success and transparent governance are non-negotiable pillars of our growth.”
